D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Comcast
CMCSA
|
+$346M |
| 2 |
Wells Fargo
WFC
|
+$285M |
| 3 |
IBM
IBM
|
+$264M |
| 4 |
Qualcomm
QCOM
|
+$252M |
| 5 |
Mondelez International
MDLZ
|
+$214M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
+$377M |
| 2 |
PayPal
PYPL
|
+$310M |
| 3 |
NVIDIA
NVDA
|
+$267M |
| 4 |
SPDR S&P 500 ETF Trust
SPY
|
+$266M |
| 5 |
AABA
Altaba Inc. Common Stock
AABA
|
+$264M |
Sector Composition
| 1 | Technology | 17.21% |
| 2 | Healthcare | 12.97% |
| 3 | Consumer Discretionary | 12.74% |
| 4 | Financials | 10.33% |
| 5 | Communication Services | 10.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PHX
2276
DELISTED
PHX Minerals
PHX
| $226K | ﹤0.01% |
+9,500
| New | +$226K |
|
|
SLCA
2277
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $226K | ﹤0.01% |
7,278
-209,532
| -97% | -$6.51M |
|
2278
ICU Medical
ICUI
$3.22B
| $224K | ﹤0.01% |
1,207
-1,833
| -60% | -$340K |
|
2279
Immunic
IMUX
$84.6M
| $224K | ﹤0.01% |
1,110
+36
| +3% | +$7.27K |
|
2280
Cartesian Therapeutics
RNAC
$265M
| $224K | ﹤0.01% |
+409
| New | +$224K |
|
|
TREC
2281
DELISTED
Trecora Resources
TREC
| $224K | ﹤0.01% |
16,862
-1,491
| -8% | -$19.8K |
|
|
PKD
2282
DELISTED
Parker Drilling Company
PKD
| $224K | ﹤0.01% |
13,555
+2,609
| +24% | +$43.1K |
|
2283
New Mountain Finance
NMFC
$1.12B
| $223K | ﹤0.01% |
15,668
-4,580
| -23% | -$65.2K |
|
2284
Element Solutions
ESI
$6.35B
| $222K | ﹤0.01% |
+19,877
| New | +$222K |
|
2285
Guess, Inc.
GES
$880M
| $222K | ﹤0.01% |
+13,060
| New | +$222K |
|
2286
Kopin
KOPN
$371M
| $222K | ﹤0.01% |
53,336
+19,858
| +59% | +$82.7K |
|
|
LORL
2287
DELISTED
Loral Space and Communications, Inc.
LORL
| $222K | ﹤0.01% |
+4,490
| New | +$222K |
|
2288
Dillards
DDS
$9.03B
| $221K | ﹤0.01% |
3,950
-12,746
| -76% | -$713K |
|
|
ALDR
2289
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $221K | ﹤0.01% |
+18,038
| New | +$221K |
|
2290
Lifecore Biomedical
LFCR
$273M
| $220K | ﹤0.01% |
+17,006
| New | +$220K |
|
2291
Univest Financial
UVSP
$903M
| $219K | ﹤0.01% |
+6,831
| New | +$219K |
|
2292
Voyager Therapeutics
VYGR
$236M
| $219K | ﹤0.01% |
+10,621
| New | +$219K |
|
|
INFN
2293
DELISTED
Infinera Corporation Common Stock
INFN
| $218K | ﹤0.01% |
24,562
-94,289
| -79% | -$837K |
|
2294
WSFS Financial
WSFS
$3.25B
| $217K | ﹤0.01% |
+4,455
| New | +$217K |
|
2295
Dentsply Sirona
XRAY
$2.77B
| $215K | ﹤0.01% |
+3,592
| New | +$215K |
|
2296
SS&C Technologies
SSNC
$21.7B
| $212K | ﹤0.01% |
+5,277
| New | +$212K |
|
|
EACQW
2297
DELISTED
Easterly Acquisition Corp.
EACQW
| $212K | ﹤0.01% |
250,000
| – | – |
|
|
EGLT
2298
DELISTED
Egalet Corporation
EGLT
| $211K | ﹤0.01% |
+165,056
| New | +$211K |
|
2299
Destination XL Group
DXLG
$69.5M
| $210K | ﹤0.01% |
110,435
-21,322
| -16% | -$40.5K |
|
2300
B. Riley Financial
RILY
$162M
| $210K | ﹤0.01% |
+12,318
| New | +$210K |
|